187 related articles for article (PubMed ID: 35949620)
1. Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling.
Xu Z; Huang L; Zhang T; Liu Y; Fang F; Wu X; Chen W; Lan L; Zhang Y; Li N; Hu P
Oncol Lett; 2022 Sep; 24(3):304. PubMed ID: 35949620
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway.
Huang L; Liu F; Liu X; Niu L; Sun L; Fang F; Ma K; Hu P
Cancer Chemother Pharmacol; 2024 Mar; 93(3):203-213. PubMed ID: 38141074
[TBL] [Abstract][Full Text] [Related]
3. Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells.
Tang Q; Liu L; Zhang H; Xiao J; Hann SS
Drug Des Devel Ther; 2020; 14():577-589. PubMed ID: 32103900
[TBL] [Abstract][Full Text] [Related]
4. Shikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK.
Hao Z; Qian J; Yang J
Oncol Lett; 2015 Feb; 9(2):629-633. PubMed ID: 25621031
[TBL] [Abstract][Full Text] [Related]
5. S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.
Li A; Gu Y; Li X; Sun H; Zha H; Xie J; Zhao J; Huang M; Chen L; Peng Q; Zhang Y; Weng Y; Zhou L
Oncol Lett; 2018 Apr; 15(4):5685-5693. PubMed ID: 29552203
[TBL] [Abstract][Full Text] [Related]
6. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
7. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways.
Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
[TBL] [Abstract][Full Text] [Related]
8. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
[TBL] [Abstract][Full Text] [Related]
9. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway.
Zhu YG; Lv YX; Guo CY; Xiao ZM; Jiang QG; Kuang H; Zhang WH; Hu P
Life Sci; 2021 Apr; 270():119112. PubMed ID: 33508300
[TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
11. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
12. Shikonin inhibits the cell viability, adhesion, invasion and migration of the human gastric cancer cell line MGC-803 via the Toll-like receptor 2/nuclear factor-kappa B pathway.
Liu JP; Liu D; Gu JF; Zhu MM; Cui L
J Pharm Pharmacol; 2015 Aug; 67(8):1143-55. PubMed ID: 25880237
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin E inhibits the proliferation of glioblastoma cells via FAK/AKT/GSK3β pathway.
Chen W; Liu F; Lin X; Li L; Chen W; Zhang T; Liu Y; Niu L; Zhang Y; Hu P
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921057
[TBL] [Abstract][Full Text] [Related]
14. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
15. Genistein inhibits migration and invasion of cervical cancer HeLa cells by regulating FAK-paxillin and MAPK signaling pathways.
Chen C; Wang Y; Chen S; Ruan X; Liao H; Zhang Y; Sun J; Gao J; Deng G
Taiwan J Obstet Gynecol; 2020 May; 59(3):403-408. PubMed ID: 32416888
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of NK cells proliferation and function by Shikonin.
Li Y; Lu H; Gu Y; Ning Z; Cao T; Chen C; Hu C; Tao M
Immunopharmacol Immunotoxicol; 2017 Jun; 39(3):124-130. PubMed ID: 28303727
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
18. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
[TBL] [Abstract][Full Text] [Related]
19. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
[TBL] [Abstract][Full Text] [Related]
20. Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway.
Jia L; Zhu Z; Li H; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2662-2669. PubMed ID: 31257936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
